The safety of amphotericin B lipid complex in patients with prior severe intolerance to liposomal amphotericin B.
Dimitrios Farmakiotis, Frank P Tverdek, Dimitrios P Kontoyiannis
Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013 MarThe tolerability of amphotericin B lipid complex in patients with previous severe infusion reactions to liposomal amphotericin B is unclear. We reviewed the charts of 40 such patients at a tertiary care cancer center and found that amphotericin B lipid complex administration was uneventful in 34 patients (85% [95% confidence interval, 69%-93%]).
Citation
Dimitrios Farmakiotis, Frank P Tverdek, Dimitrios P Kontoyiannis. The safety of amphotericin B lipid complex in patients with prior severe intolerance to liposomal amphotericin B. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013 Mar;56(5):701-3
Mesh Tags
Substances
PMID: 23166189
View Full Text
